
|Articles|May 12, 2004
Various therapies manage kidney stone disease
Mission Pharmacal provides the following therapies for the medical managementof kidney stone disease: potassium citrate wax matrix (Urocit-K) tablets;tiopronin (Thiola) tablets; acetohydroxamic acid (Lithostat) tablets; andcellulose sodium phosphate powder (Calcibind).
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5










